Crossmark

A randomized trial assessing the efficacy of Silymarin on endometrioma-related manifestations

Published Online: 2022-10-20

Authors

Mirzaei, Negin

Jahanian Sadatmahalleh, Shahideh

Rouholamin, Safoura

Nasiri, Malihe
License Information

Text and Data Mining valid from 2022-10-20

Version of Record valid from 2022-10-20
More Information

Article History

Received: 7 May 2022

Accepted: 10 October 2022

First Online: 20 October 2022

Competing interests

: The authors declare no competing interests.

Document is current